Determination of guaiphenesin and sodium benzoate in Liqufruta garlic cough medicine by high performance liquid chromatography

  • G. A. Shabir


A new and simple isocratic high-performance liquid chromatographic method with ultraviolet detection is described for simultaneous determination of active guaiphenesin and preservative sodium benzoate in Liqufruta garlic cough medicine formulation. The chromatographic separation was achieved using a Zorbax CN; 150 mm × 4.6 mm and 5 μm particle size column employing acetonitrile and water (20: 80, v/v) containing 0.1% formic acid (pH 3.5 ± 0.05) as the mobile phase. The method was validated with respect to linearity, range, precision, accuracy, specificity, limit of detection and limit of quantitation. The both analytes were detected by UV-Vis detector at 245 nm. The method was linear over the concentration range of 0.2–0.8 mg/mL and 0.02–0.06 mg/mL for guaiphenesin and sodium benzoate, respectively. The limit of detection was found to be 0.14 μg/mL for GP and 0.06 μg/mL for SB and the quantification limit was 0.54 μg/mL for GP and 0.22 for SB. Accuracy, evaluated as recovery, was in the range of 97.8–100.0%. Intra-day precision and intermediate precision showed relative standard deviation <1% in each case.


guaiphenesin sodium benzoate method validation cough medicine formulation HPLC determination 


  1. 1.
    Pappano, N.B., Micalizzi, Y.C., Debattista, N.B., and Ferretti, F.H., Talanta, 1997, vol. 44, no. 4, p. 633.CrossRefGoogle Scholar
  2. 2.
    Lee, A.R. and Hu, T.M., J. Pharm. Biomed. Anal., 1994, vol. 12, no. 6, p. 747.CrossRefGoogle Scholar
  3. 3.
    Abdel-Hay, M.H., EI-Din, M.S., and Abuirjeie, M.A., Analyst, 1992, vol. 2, no. 117, p. 157.CrossRefGoogle Scholar
  4. 4.
    Tapsoba, I., Belgaied, J.E., and Boujel, K., J. Pharm. Biomed. Anal., 2005, vol. 38, no. 1, p. 162.CrossRefGoogle Scholar
  5. 5.
    Pomponio, R., Gotti, R., Hudaib, M., Andrisano, V., and Cavrini, V., J. Sep. Sci., 2001, vol. 24, no. 2, p. 258.CrossRefGoogle Scholar
  6. 6.
    Grosa, G., Del Grosso, E., Russo, R., and Allegrone, G., J. Pharm. Biomed. Anal., 2006, vol. 41, no. 3, p. 798.CrossRefGoogle Scholar
  7. 7.
    Indrayanto, G., Sunarto, A., and Adrian, Y., J. Pharm. Biomed. Anal., 1995, vol. 13, no. 12, p. 1555.CrossRefGoogle Scholar
  8. 8.
    Wilcox, M.L. and Stewart, J.T., J. Pharm. Biomed. Anal., 2000, vol. 23, no. 5, p. 909.CrossRefGoogle Scholar
  9. 9.
    Vasudevan, M., Ravisankar, S., Sathiyanarayanan, A., and Chandan, R.S., J. Pharm. Biomed. Anal., 2000, vol. 24, p. 25.CrossRefGoogle Scholar
  10. 10.
    International Conference on Harmonization (ICH), Validation of Analytical Procedures, Q2(R1), 2005.Google Scholar
  11. 11.
    Reviewer Guidance: Validation of Chromatographic Methods, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 1994.Google Scholar
  12. 12.
    Shabir, G.A., J. Chromatogr. A, 2003, vol. 987, nos. 1–2, p. 57.CrossRefGoogle Scholar
  13. 13.
    Shabir, G.A., Lough, W.J., Shafique, A.A., and Bradshaw, T.K., J. Liq. Chromatogr. Rel. Technol., 2007, vol. 30, no. 3, p. 311.CrossRefGoogle Scholar
  14. 14.
    Shabir, G.A., J. Validation Technol., 2004, vol. 10, no. 4, p. 314.Google Scholar
  15. 15.
    Shabir, G.A., Pharm. Technol. Eur., 2004, vol. 16, no. 3, p. 37.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2011

Authors and Affiliations

  • G. A. Shabir
    • 1
  1. 1.School of Life SciencesOxford Brookes UniversityOxfordUK

Personalised recommendations